Project CBD Newsletter: Trump Signs Order to Reclassify Cannabis as Schedule III, FDA/DEA Hemp Enforcement Challenges, Microdosing THC and CBD for Alzheimer’s, and More
This week’s newsletter covers cannabis rescheduling, hemp regulation enforcement hurdles, promising cannabinoid research for Alzheimer’s disease and hypertension, CBD use trends on college campuses, the environmental toll of drug prohibition, and the WHO’s new push […]